A retrospective study to assess long-term survival of biological therapy in psoriatic arthritis patients
Latest Information Update: 10 Jun 2022
At a glance
- Drugs Adalimumab (Primary) ; Apremilast (Primary) ; Certolizumab pegol (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
Most Recent Events
- 01 Jun 2022 Results published in the Rheumatology International
- 18 May 2022 New trial record